$2.30 0.05 (+2.23%)
11/25/2009 2:42 PM

DURECT Corp (DRRX)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners